Related references
Note: Only part of the references are listed.Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation
Tyler H. Rork et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils
Dharini van der Hoeven et al.
MOLECULAR PHARMACOLOGY (2008)
Mechanisms of disease: Myocardial reperfusion injury
Derek M. Yellon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
NKT cell activation mediates neutrophil IFN-γ production and renal ischemia-reperfusion injury
Li Li et al.
JOURNAL OF IMMUNOLOGY (2007)
The A(2a)/A(2b) receptor antagonist ZM-241385 blocks the cardioprotective effect of adenosine agonist pretreatment in in vivo rat myocardium
Robert D. Lasley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation
Courtney M. Lappas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Stimulation of A2A-adenosine receptors after myocardial infarction suppresses inflammatory activation and attenuates contractile dysfunction in the remote left ventricle
MC Toufektsian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Targeting the inflammatory response in healing myocardial infarcts
Nikolaos G. Frangogiannis
CURRENT MEDICINAL CHEMISTRY (2006)
Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting
A Micari et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine
H Kin et al.
CARDIOVASCULAR RESEARCH (2005)
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)
AM Ross et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes
ZQ Yang et al.
CIRCULATION (2005)
Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium
DK Glover et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury
J Vinten-Johansen
CARDIOVASCULAR RESEARCH (2004)
Of mice and dogs: Species-specific differences in the inflammatory response following myocardial infarction
O Dewald et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs
JA Auchampach et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Pharmacological stress myocardial perfusion imaging with the potent and selective A2A adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection
DK Glover et al.
CIRCULATION (2001)
Beneficial effects of adenosine A2a agonist CGS-21680 in infarcted and stunned porcine myocardium
RD Lasley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A2A receptor agonists
GW Sullivan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection
J Linden
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Share Paper
